Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets (Q40358585)

19 September 2017

title

Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets (English)

1 reference

19 September 2017

C C Berthier

1

1 reference

19 September 2017

N Lods

2

1 reference

19 September 2017

S A Joosten

3

1 reference

19 September 2017

C van Kooten

4

1 reference

19 September 2017

D Leppert

5

1 reference

19 September 2017

R L P Lindberg

6

1 reference

19 September 2017

A Kappeler

7

1 reference

19 September 2017

F Raulf

8

1 reference

19 September 2017

E E Sterchi

9

1 reference

19 September 2017

D Lottaz

10

1 reference

19 September 2017

H-P Marti

11

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

69

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

358-368

1 reference

The Banff 97 working classification of renal allograft pathology

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Structure of homo- and hetero-oligomeric meprin metalloproteases. Dimers, tetramers, and high molecular mass multimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Proteolytic remodeling of extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Gene transfer of metalloproteinase transin induces aberrant behavior of cultured mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Biosynthesis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase: disulfide-linked dimers are formed at the site of synthesis in the rough endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Heterologously overexpressed, affinity-purified human meprin alpha is functionally active and cleaves components of the basement membrane in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

The role of meprin A in the pathogenesis of acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

TACE inhibition: a new approach to treating inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Telomere shortening and cellular senescence in a model of chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

An old enzyme with a new function: purification and characterization of a distinct matrix-degrading metalloproteinase in rat kidney cortex and its identification as meprin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Changes in serum concentrations of matrix metalloproteinases in kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

The role of metalloelastase in immune complex-induced acute lung injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Activation of human meprin-alpha in a cell culture model of colorectal cancer is triggered by the plasminogen-activating system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Secretion of human meprin from intestinal epithelial cells depends on differential expression of the alpha and beta subunits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000049

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000049

1 reference

19 September 2017

1 reference